SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001513160-13-000031
Filing Date
2013-05-29
Accepted
2013-05-29 15:03:54
Documents
4
Period of Report
2013-05-22
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 GENESIS BIOPHARMA CURRENT REPORT gnbpcurrentreport.htm 8-K 52941
2 AMENDMENT TO BYLAWS ex31.htm EX-3.1 10494
3 STOCK PURCHASE AGREEMENT ex101.htm EX-10.1 148773
4 EXCHANGE AGREEMENT ex102.htm EX-10.2 119668
  Complete submission text file 0001513160-13-000031.txt   333483
Mailing Address 1601 N. SEPULVEDA BLVD., #632 MANHATTAN BEACH CA 90266
Business Address 1601 N. SEPULVEDA BLVD., #632 MANHATTAN BEACH CA 90266 866-963-2220
Genesis Biopharma, Inc (Filer) CIK: 0001425205 (see all company filings)

IRS No.: 753254381 | State of Incorp.: NV | Fiscal Year End: 0528
Type: 8-K | Act: 34 | File No.: 000-53127 | Film No.: 13878080
SIC: 4731 Arrangement of Transportation of Freight & Cargo